Dorothea Terhorst-Molawi

8PUBLICATIONS
64CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Human impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2025
Mucosal angioedema involving the oropharynx signals severe cold urticaria: COLD-CE study insights.

Mojca Bizjak, Daria Fomina, Jonny Peter

|May 29, 2025
Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitors.

Sherezade Moñino-Romero, Niklas Amadeus Mahnke, Dorothea Terhorst-Molawi

|Nov 17, 2022
Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria.

Dorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz

|Mar 08, 2022
Adrenaline autoinjector is underprescribed in typical cold urticaria patients.

Mojca Bizjak, Mitja Košnik, Dejan Dinevski

|Dec 04, 2021
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study.

Mojca Bizjak, Mitja Košnik, Dejan Dinevski

|Apr 02, 2021
Severe cold urticaria can point to an underlying clonal mast cell disorder.

Mojca Bizjak, Marcus Maurer, Mitja Košnik

Pageof 2